HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
3 hedge funds and large institutions have $4.44M invested in Hepion Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
+2
Holders Change %
+200%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$1.37M |
| 2 |
TCIM
TIAA CREF Investment Management
New York
|
+$866K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$510K |
